Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study

Clinical trial NCT05247931 · UNKNOWN

Trial details

NCT number: NCT05247931
Sponsor: Fadoi Foundation, Italy
Status: UNKNOWN
Study type: OBSERVATIONAL

Cerebrovascular Disease

Start date: 2019-11-07
Primary completion: 2022-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.